A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

NCT04034498 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-01-16

No results posted yet for this study

Summary

The objective of this registry is to gain more insight on the clinical use of the Occlutech perimembranous VSD occluder.

Conditions

  • Perimembranous Ventricular Septal Defect

Sponsors & Collaborators

  • Occlutech International AB

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-07
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • Ireland
  • Thailand
  • Turkey (Türkiye)
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04034498 on ClinicalTrials.gov